Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-005367
Filing Date
2021-02-11
Accepted
2021-02-11 06:04:23
Documents
9
Period of Report
2021-02-11

Document Format Files

Seq Description Document Type Size
1 6-K meso-6k_20210211.htm 6-K 24160
2 EX-99.1 meso-ex991_6.htm EX-99.1 78492
3 GRAPHIC gwzbqvzj440c000006.jpg GRAPHIC 60970
4 GRAPHIC gwzbqvzj440c000002.jpg GRAPHIC 21215
5 GRAPHIC gwzbqvzj440c000001.jpg GRAPHIC 10691
6 GRAPHIC gwzbqvzj440c000003.jpg GRAPHIC 8191
7 GRAPHIC go5zabbvi0zm000001.jpg GRAPHIC 631
8 GRAPHIC gwzbqvzj440c000004.jpg GRAPHIC 115704
9 GRAPHIC gwzbqvzj440c000005.jpg GRAPHIC 114764
  Complete submission text file 0001564590-21-005367.txt   561961
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 21616494
SIC: 2836 Biological Products, (No Diagnostic Substances)